JACK CASTEEL BRUNER II, MD

Plain English
This study focused on how the immune system interacts with liver transplants and used mathematical modeling to understand these processes better. The researchers identified that specific immune cells, particularly cytotoxic T cells and a substance called IL-2, play crucial roles in liver transplant health, highlighting their impact on organ damage. This information can help doctors better monitor liver transplant patients and develop new treatments to improve their long-term health. Who this helps: Patients receiving liver transplants and their doctors.

Plain English
This research paper studied how advanced mathematical methods can improve outcomes for patients undergoing liver transplantation (LT). It found that using these techniques could potentially increase the 5-year survival rate of transplanted livers, which currently stands at 70%, by better matching donors and recipients and personalizing treatment after surgery. This matter because improving graft utilization and patient care can save more lives and enhance recovery for those needing a liver transplant. Who this helps: Patients waiting for liver transplants and their doctors.

Plain English
This research focused on the Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), which harms pigs and causes over $500 million in losses annually in the USA. The scientists identified 63 protein interactions involved in how the virus enters and infects pigs and pinpointed 75 key areas on the virus proteins that are essential for its infection process. They also developed 56 new potential vaccine components designed to better protect pigs from this virus by using advanced modeling techniques. Who this helps: This research benefits pig farmers and the swine industry by aiming to create more effective vaccines for PRRSV.

Plain English
This study investigated new ways to diagnose liver transplant rejection without the need for invasive biopsies, which can be risky and costly. Researchers found that new noninvasive methods, including certain biomarkers and the use of artificial intelligence, might detect rejection more accurately and earlier than traditional biopsy methods. These advancements could help reduce complications from monitoring while improving the care of liver transplant patients. Who this helps: This benefits liver transplant patients and their doctors by providing safer and more effective monitoring options.

Plain English
This study looked at how to better diagnose rejection of transplanted livers, focusing on noninvasive methods instead of the usual liver biopsy. Researchers found that analyzing certain types of DNA fragments (dd-cfDNA) and antibodies (DSA) showed promise in indicating rejection status, which could help doctors adjust immunosuppressive treatments more effectively. Although these noninvasive methods aren't ready to fully replace biopsies yet, they could significantly improve how rejection is diagnosed in the future. Who this helps: Patients who have received liver transplants.

Plain English
This study focused on the physical strain that ophthalmologists experience while performing simulated cataract surgeries. Researchers found that after practicing on a virtual reality simulator, most participants reported more spinal issues, with an average increase in detected problems of 1.3 levels in the spine, while those who rested showed improvements. This is important because it highlights the need for better ergonomic practices to support eye surgeons and potentially reduce their risk of developing lasting injuries. Who this helps: This helps ophthalmologists and their trainers understand how to improve working conditions and reduce injury risk.

Plain English
This study looked at hiccups (known as singultus), particularly after surgery. The researchers found that using osteopathic manipulative treatment helped one man who had persistent hiccups following an operation, managing his symptoms effectively without serious side effects. This is important because it offers a new option for treating postoperative hiccups when other methods fail. Who this helps: Patients recovering from surgery experiencing persistent hiccups.

Plain English
This study looks at a rare type of cancer called primary rhabdomyosarcoma (RMS) that occurs in the pineal gland of the brain. The case involved an adult patient who was diagnosed and received treatment based on children's cancer protocols, but sadly, their disease worsened quickly, and they lived only 5 months after being diagnosed. This situation highlights the need for better understanding and treatment options for this uncommon and severe condition. Who this helps: Patients with primary rhabdomyosarcoma and their doctors.

Plain English
This study looked at how far patients from different racial and ethnic backgrounds travel to participate in cancer clinical trials and whether their access to these trials is affected by where they live. Researchers found that from 2006 to 2009, patients traveled an average of 11.6 miles to join trials, with White patients traveling the farthest at 12.9 miles, compared to Latinos at 8.2 miles and African Americans at only 5.9 miles. Understanding these travel distances helps identify barriers to access for minority patients and suggests strategies to improve participation in clinical trials. Who this helps: This benefits patients, especially those from minority groups seeking access to cancer clinical trials.

Plain English
This research looked at how people found positive outcomes after the devastation caused by Hurricanes Katrina and Rita in 2005. Two studies showed that many adults, particularly those aged 47 to 95, reported benefits such as being better prepared for future disasters, seeing improvements in their cities, and increased acts of kindness among strangers. For instance, while older adults were less likely to identify these positives, overall, understanding these benefits can help people cope better and become more resilient after disasters. Who this helps: This research benefits disaster survivors and mental health professionals by providing insights into coping strategies.

Plain English
This study examined how well the Functional Movement Screen (FMS) can predict the risk of injuries in active people. Researchers found that the FMS can identify individuals at risk of injury with about 75% accuracy, which means it correctly spots many people who could get hurt. This matters because knowing who is at risk can help prevent injuries through proper training or interventions. Who this helps: This helps athletes and fitness professionals by providing a way to identify and support individuals who are more likely to get injured.

Plain English
This study looked at a patient who was thought to have a recurring malignant brain tumor based on imaging scans. However, after surgery, doctors found that it was actually a different condition called papillary endothelial hyperplasia, which mimics a tumor. This finding is important because it emphasizes the need for careful diagnosis, as misdiagnosis can lead to incorrect treatment decisions. Who this helps: This helps patients with brain tumors and their doctors.

Plain English
This study looked at a rare type of tumor called a Ewing tumor that developed in the lumbar spine of a 38-year-old man. The doctors initially thought it was a different type of tumor based on MRI results, but tests showed it was a malignant round-cell tumor, confirmed by special testing. This case is significant because Ewing tumors in the lumbar region are extremely rare, with only eight similar cases documented before, highlighting the need for awareness and careful diagnosis of unusual tumors in this area. Who this helps: This helps doctors by providing insights into diagnosing rare spinal tumors.

Plain English
This study looks at a rare problem that can occur after someone gets a pacemaker, specifically something called superior vena cava syndrome. The case involves a 54-year-old woman who experienced swelling and spasms in her neck for two months, which was linked to the pacemaker she had since 1997. After imaging tests showed a blockage in a major vein, the woman had a procedure to open the vein and is now symptom-free. Who this helps: This helps patients with pacemakers and their doctors by highlighting potential complications and treatment options.

Plain English
The study looks at a birth defect called myelomeningocele, or spina bifida, which can severely affect a person's life. In some specialized centers, doctors have started performing surgeries on unborn babies, with initial results showing fewer cases of shunt-dependent hydrocephalus—a condition that requires a pump to drain fluid from the brain. However, the overall improvement in patients’ long-term neurological health has not been as strong as hoped, prompting a major trial in the U.S. to compare this prenatal surgery to the usual care after birth, with the aim of understanding the benefits and risks involved. Who this helps: This research provides valuable insights for patients with spina bifida and their families, as well as doctors making treatment decisions.

Plain English
This study looked at new automated methods for extracting RNA from different types of samples, like blood and tissue, to help speed up research on gene expression. The researchers found that using these automated systems allowed them to process more samples quickly while still getting reliable results. This is important because it helps scientists analyze genetic information more efficiently. Who this helps: This benefits researchers and medical laboratories focused on gene analysis.

Plain English
Researchers studied 177 tumor samples from patients with oligodendrogliomas, a type of brain cancer, and found that a specific gene called SHREW1 is often deleted in these tumors, occurring in 60-80% of cases. The loss of SHREW1 seems to allow cancer cells to spread more easily, as restoring the gene's expression reduced their ability to stick together and move. This is important because it helps explain how these tumors develop and could lead to new approaches for treatment. Who this helps: Patients with oligodendrogliomas and their doctors.

Plain English
This study looked at different methods for assessing how fast certain brain tumors, specifically low and intermediate-grade astrocytomas, are growing. Researchers found that using a marker called phospho-histone H3 (pHH3) was a clear and reliable way to measure cell division in these tumors. This method not only helped distinguish between tumor grades but also better predicted patient survival compared to traditional methods; for every 1,000 cells measured, pHH3 provided more accurate survival data. Who this helps: This benefits patients with astrocytomas by improving their diagnosis and treatment decisions.

Plain English
This study examined 177 tumors to see how deleting a part of chromosome 1p affects certain genes in oligodendrogliomas, a type of brain tumor. It specifically found that the DFFB gene had lower levels of expression in all tested tumors with 1p deletions, suggesting that losing this part of the chromosome may play a role in the development of these tumors. Understanding this link is important because it could help researchers develop better targeted therapies for patients with oligodendrogliomas. Who this helps: This information helps patients with oligodendrogliomas and their doctors.

Plain English
This study looked at how effective high-dose chemotherapy (HDCT) is for children with a serious brain tumor called high-grade astrocytoma. Researchers followed 102 children, but 76 were fully evaluated. They found that only 24% survived for five years, and the different drug combinations used did not significantly improve outcomes compared to traditional treatments. Since serious side effects were common and many children couldn't complete the treatment, the authors concluded that HDCT doesn't provide extra benefits over standard care. Who this helps: This helps doctors and families of children diagnosed with high-grade astrocytoma by providing clearer treatment expectations.

Plain English
This research focused on a condition called gastroschisis, where a baby is born with some of their intestines outside their body due to a hole in the abdominal wall. The study found that a procedure called amnioexchange, which involves regularly replacing the amniotic fluid, may help reduce damage to the intestines and inflammation in affected babies. With the survival rate over 90%, improving treatment practices could lead to better health outcomes for these infants. Who this helps: This benefits expecting parents and healthcare providers caring for babies with gastroschisis.

Plain English
This study looked at how consumers impact healthcare costs and quality by making choices about their care. It found that when consumers are more informed and responsible for their decisions, it can lead to better health outcomes and lower costs. For example, giving patients better tools and information can help them navigate their healthcare options and make wiser choices. Who this helps: This benefits patients significantly by empowering them to take control of their healthcare decisions.

Plain English
This study looked at a new treatment approach for patients with anaplastic gliomas, a type of brain tumor. Researchers treated 90 patients with a combination of radiation and chemotherapy, finding that the average survival time was about 28 months. Notably, 25% of patients survived for over 8 years, but some experienced serious side effects, including brain damage, which highlights the need to balance effectiveness with safety in treatment plans. Who this helps: This information is beneficial for patients with anaplastic gliomas and their doctors as they consider treatment options.

Plain English
This study tested the effectiveness of a drug called temozolomide in 138 patients with recurrent glioblastoma multiforme (GBM), a type of brain cancer that is difficult to treat. The results showed that only 18% of patients did not see the disease worsen after six months, with a median survival time of 5.4 months. Importantly, patients did report improvements in their quality of life during treatment, and the drug had a manageable safety profile. Who this helps: This benefits patients with recurrent glioblastoma multiforme and their doctors by providing treatment options to improve survival and quality of life.

Plain English
This study looked at how a lack of vitamin K, either from a poor diet or from the blood thinner warfarin, affects bone health in young female rats. The researchers found that low vitamin K levels led to a 17% increase in a certain type of bone marker that indicates bone turnover, but there was no overall impact on bone density or strength. This matters because it highlights that while vitamin K is important for bone biology, not having enough of it doesn’t necessarily prevent healthy bone development in this context. Who this helps: This helps patients who are on blood thinners like warfarin and may have concerns about their bone health.

Plain English
This study compared two treatments, temozolomide (TMZ) and procarbazine (PCB), for patients with glioblastoma multiforme who had their cancer return after initial treatment. The results showed that 21% of patients on TMZ did not see their disease progress after six months, compared to only 8% for those taking PCB. Additionally, TMZ patients had a higher chance of surviving six months at 60% compared to 44% for PCB patients. This matters because it suggests that TMZ could provide better outcomes for patients dealing with this aggressive brain cancer. Who this helps: This helps patients with glioblastoma multiforme and their doctors in choosing more effective treatment options after the cancer relapses.

Plain English
This study examined how a substance called brefeldin A affects the release of a neurotransmitter called acetylcholine from specific brain cancer cells known as C6BU-1. The researchers found that after treating the cells with brefeldin A for 24 to 36 hours, the release of acetylcholine dropped significantly—by more than half in just 24 hours—along with a decrease in important proteins that help with this release. This is important because it highlights a potential mechanism in how neurotransmitter release can be disrupted, which could have implications for understanding certain neurological disorders and cancers. Who this helps: This helps patients with brain cancer and related neurological conditions.

Plain English
This study looked at bladder function in 25 infants with a spinal condition called myelodysplasia, who had surgical closure of their spinal defect before birth. It found that 6% had uncontrolled bladder contractions, 43% had a non-functioning bladder, and many had reduced bladder capacity compared to what is typical for their age. While early intervention seems to lead to fewer urinary tract infections and better management, the bladder functions are similar to those of babies with myelodysplasia who did not receive prenatal surgery. Who this helps: This research benefits doctors and caregivers working with infants with spinal conditions, helping them understand bladder health management better.

Plain English
This research looks at how a centralized team for automation at Glaxo Wellcome operates within a flexible organizational culture that promotes communication across different parts of the company. The team has experienced both successes and challenges in providing support and training for laboratory technology. For instance, while they have supported various businesses within the Development organization, they need to improve their influence on automation strategies globally. Who this helps: This benefits employees and organizations involved in laboratory automation and development.

Plain English
This study looked at bone health in older female rhesus monkeys, particularly focusing on how osteoarthritis (OA) affects the measurement of bone density in the spine. Researchers found that a new analysis method showed lower bone density in older monkeys compared to a standard method, revealing that 67% of monkeys aged 19 and older were classified as having low bone density (osteopenia/osteoporosis) using the new method, compared to just 42% with the standard method. This is important because it indicates that using better analysis techniques can help identify bone health issues sooner, which is crucial for managing aging in both monkeys and potentially humans. Who this helps: This helps researchers and veterinarians working with aging primates, as well as humans concerned about bone health.

Plain English
This study focused on special neurons in sand crabs that respond to stretching. Researchers found that these neurons have a resting electrical charge of about -57 mV and react to stretching in a way that creates a steady signal, regardless of the strength of the stretch. This matters because understanding how these neurons work can help scientists learn more about how crabs and similar animals sense their environment, which could have broader implications for studying sensory systems in other species. Who this helps: This helps researchers studying animal biology and sensory systems.

Plain English
This study looked at the effectiveness and safety of a drug called temozolomide in patients with two types of recurring brain tumors, anaplastic astrocytoma and anaplastic oligoastrocytoma. Out of 162 patients, 46% were progression-free after six months, with an average survival time of 13.6 months and a response rate of 35%, meaning some tumors shrank or stabilized. These findings are significant because they show that temozolomide can help control these aggressive tumors with manageable side effects. Who this helps: This benefits patients with anaplastic astrocytoma or oligoastrocytoma who are facing their first relapse.

Plain English
This study looked at pediatric oligodendrogliomas, which are rare brain tumors in children, to understand their treatment and outcomes. Researchers analyzed records from 19 children treated at MD Anderson Cancer Center, finding that 65% were alive five years after diagnosis, and 30% experienced fewer seizures after treatment. Importantly, younger children had better outcomes, and the way tumors were classified helped predict survival, but the type of follow-up treatment used did not show a clear impact on survival rates. Who this helps: This benefits children with oligodendrogliomas and their families, as well as doctors treating these patients.

Plain English
This study looked at how the drug zoledronate affects bone density in female rhesus monkeys that had their ovaries removed, which mimics menopause in women. Over 69 weeks, the monkeys that received zoledronate saw a stop in bone loss, with the drug working better at higher doses; specifically, bone loss was blocked as much as 8%, compared to untreated monkeys. This is important because it shows that zoledronate could help prevent bone weakening in women after menopause. Who this helps: This helps postmenopausal women at risk of osteoporosis.

Plain English
This study looked at treating brain tumors in infants and young children using a chemotherapy regimen called MOPP instead of radiation after surgery. Out of 17 children treated, 10 have survived without signs of disease, including 8 out of 12 with medulloblastoma living an average of 10.6 years. This approach is important because it helps improve survival rates and reduces long-term health issues associated with radiation, which can stunt growth and affect intelligence. Who this helps: This benefits young patients with brain tumors and their families by providing a treatment option that promotes better long-term health.

Plain English
Researchers studied how a gene called p16, which is often missing in brain tumors called gliomas, affects tumor growth. They used a special virus to deliver the p16 gene to glioma cells, leading to a significant slowdown in cell growth and changes in the cells’ structure; over 50% of the treated cells stopped dividing normally. This is important because restoring p16 could offer new treatment options for patients with gliomas, which are difficult to treat with current methods. Who this helps: This helps patients with gliomas and their doctors by providing potential new therapies.

Plain English
This study looked at mutations in a gene called p16 in 35 malignant gliomas, a type of brain tumor, and found that while no mutations appeared in initial tests, further analysis revealed mutations in 5 tumors. These mutations were observed in a small portion of the tumor cells, ranging from 1.3% to 22%. This finding indicates that p16 mutations occur in advanced glioblastomas, which could help in understanding the progression of these tumors and developing targeted treatments. Who this helps: This helps doctors and researchers studying glioblastomas and their treatment options.

Plain English
This study examined the effects of a combination of four drugs—6-thioguanine, procarbazine, lomustine, and hydroxyurea—in treating patients with recurring types of brain cancer called malignant gliomas. Out of 77 patients studied, those with glioblastomas had only a 7% response rate, with an average progression time of 9 weeks, while 23% of anaplastic glioma patients responded, showing a median progression time of 24 weeks, extending to 50 weeks for those not previously treated with chemotherapy. These findings highlight that this drug combination may be beneficial for certain patients with anaplastic gliomas but less effective for those with glioblastomas who have previously received chemotherapy. Who this helps: This research benefits patients with anaplastic gliomas who have not been treated with certain prior chemotherapy.

Plain English
This study explored how a molecule called cyclic AMP can change fibroblast cells to take in and release a neurotransmitter called acetylcholine more effectively. Researchers found that after treating the fibroblasts for 3-6 days with cyclic AMP, the cells not only released more acetylcholine—but did so for longer periods, lasting over one second in some cases. This is important because better understanding and enhancement of neurotransmitter release can lead to new therapies for conditions involving neurotransmitter deficiencies. Who this helps: This benefits patients with neurological disorders and conditions affecting nerve communication.

Plain English
This study tested a new test to measure a hormone called canine thyroid-stimulating hormone (cTSH) in dogs and looked at how this hormone changed when dogs were made hypothyroid (a condition where they have low thyroid hormone levels). Researchers found that after inducing hypothyroidism in the dogs, their cTSH levels increased 35 times higher than normal, but after 35 days of treatment, their levels returned to normal. This test can help veterinarians diagnose different types of hypothyroidism in dogs and monitor how well treatment is working. Who this helps: This helps veterinarians and dog owners.

Plain English
This study looked at a treatment for patients with a type of brain tumor called glioblastoma multiforme. Researchers gave 83 patients a specific radiation treatment alongside a drug called carboplatin, followed by a year of chemotherapy, and found that 89% of patients received some chemotherapy, with a median survival of 55 weeks. Treatment worked better for younger patients and those who had more extensive surgery. Who this helps: This benefits patients with glioblastoma multiforme and their doctors by providing effective treatment options.

Plain English
This study looked at how two important brain chemicals, glutamate and acetylcholine, are released from nerve endings in response to calcium levels. When calcium levels were higher (between 3 and 10 mM), glutamate was released more, while lower calcium levels favored acetylcholine release. This research matters because understanding how these chemicals are released can help us learn more about brain function and the treatment of neurological conditions. Who this helps: This helps patients with neurological disorders and the doctors treating them.

Plain English
This study looked at how well different treatments work for patients with two types of brain tumors: anaplastic oligodendrogliomas and mixed gliomas. Among the 34 patients studied, those who received aggressive treatment during recurrence had a 75% chance of showing a good response, with some surviving as long as 132 months, while initial treatments were less effective, especially for anaplastic oligodendrogliomas. This research is important because it highlights the benefits of aggressive treatment for recurrent tumors, which can help improve survival outcomes for patients. Who this helps: Patients with recurrent anaplastic oligodendrogliomas and mixed gliomas.

Plain English
This study looked at a substance called 8RN-DAGal to see how it affects P-type calcium channels in frog eggs (Xenopus oocytes), which are used in research. The researchers found that 8RN-DAGal can block these channels, similar to certain toxins from spider venom, and this blockage varies depending on voltage changes. Understanding how substances like 8RN-DAGal affect calcium channels is important for developing new treatments for conditions linked to these channels. Who this helps: This benefits researchers and potentially leads to better treatments for patients with calcium channel-related health issues.

Plain English
This study looked at specific proteins in rare brain tumors called choroid plexus papillomas and carcinomas, as well as some brain metastases. Researchers found that the protein transthyretin (TTR) was not a reliable marker for diagnosing these tumors because most choroid plexus carcinomas showed weak or no staining. Out of the 13 choroid plexus tumors tested, only 2 had strong TTR staining, which limits the usefulness of TTR for making a clear diagnosis. Who this helps: This helps doctors better understand the limitations of using TTR as a marker in brain tumor diagnoses.

Plain English
This study looked at how calcium ions (Ca2+) affect the nerve cells of crayfish. Researchers found that after introducing a small amount of calcium, the nerve cells became less responsive for about 10 to 15 minutes, showing decreased input resistance and shorter action potentials. This is important because it helps us understand how nerve cells can change their activity, which could have implications for understanding similar processes in other animals, including humans. Who this helps: This helps researchers studying nerve function and potential treatments for nerve-related issues.